Neuralink, an American biotechnology company founded by Elon Musk that creates implantable brain-computer interfaces (BCIs), has had ambitious goals to revolutionize the connection between human brains and computers. Since its founding, the company has hired several high-profile neuroscientists from various universities. In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short-term, with the eventual goal of human enhancement, sometimes called transhumanism. Neuralink has only done testing on animals. However, in May, the company announced it had won FDA approval to run its first clinical trial in humans. The company's mission is to create a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow.